CXCR1 and Cognitive impairment: CXCR1 and ERK/p38 MAPK inhibition decreased activation of microglia and blockade of this route also attenuated lesions to the white matter, and the cognitive impairments induced by BCAS (Lee et al., 2013; Liu et al., 2015).